Travere Therapeutics (TVTX) Non-Current Deffered Revenue (2021 - 2024)
Travere Therapeutics (TVTX) recorded Non-Current Deffered Revenue of $888,000 in Q1 2024, down 89.9% from $8.78 million a year earlier and down 51.6% from the prior quarter.
Powered by 
Analysis
Travere Therapeutics (TVTX) Non-Current Deffered Revenue (2021 - 2024) Analysis & Trends
At the end of FY2023, Travere Therapeutics reported Non-Current Deffered Revenue of $1.84 million, down 83.2% from FY2022.
- Across earlier years, Non-Current Deffered Revenue came in at $10.93 million in FY2022 (-46.4%) and $20.38 million in FY2021.
- The Q1 2024 figure is the lowest quarterly Non-Current Deffered Revenue in data going back to Q3 2021.
- On a year-over-year basis, Non-Current Deffered Revenue has declined for seven consecutive quarters, with an average decline of 63.4% over the last seven quarters.
- Per Business Quant, the preceding three quarters came in at $1.84 million (Q4 2023), $4.57 million (Q3 2023) and $6.79 million (Q2 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | - |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | - |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | - |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | - |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | - |
| 10 | Travere Therapeutics | 5.35 Bn | 4.95 Bn | 167.41 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | 888,000.00 |
| Dec 31, 2023 | 1.84 Mn |
| Sep 30, 2023 | 4.57 Mn |
| Jun 30, 2023 | 6.79 Mn |
| Mar 31, 2023 | 8.78 Mn |
| Dec 31, 2022 | 10.93 Mn |
| Sep 30, 2022 | 12.92 Mn |
| Jun 30, 2022 | 16.24 Mn |
| Mar 31, 2022 | 19.67 Mn |
| Dec 31, 2021 | 20.38 Mn |
| Sep 30, 2021 | 24.08 Mn |
API Access
Travere Therapeutics Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=TVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "TVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=TVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();